RDHL logo

RedHill Biopharma (RDHL) Shareholders Equity

Annual Shareholders Equity

$2.07 M
+$50.47 M+104.27%

December 31, 2023


Summary


Performance

RDHL Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRDHLbalance sheetmetrics:

Quarterly Shareholders Equity

$61.00 K
-$3.41 M-98.24%

June 1, 2024


Summary


Performance

RDHL Quarterly Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRDHLbalance sheetmetrics:

Shareholders Equity Formula

Shareholders Equity = Total Assets − Total Liabilities

RDHL Shareholders Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+104.3%-98.2%
3 y3 years-85.1%-98.2%
5 y5 years-96.0%-98.2%

RDHL Shareholders Equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-76.7%+104.3%-99.3%+100.1%
5 y5-year-96.5%+104.3%-99.9%+100.1%
alltimeall time-96.7%+104.3%-99.9%+100.1%

RedHill Biopharma Shareholders Equity History

DateAnnualQuarterly
Jun 2024
-
$61.00 K(-98.2%)
Dec 2023
$2.07 M(-104.3%)
-
Jun 2023
-
$3.47 M(+73.2%)
Mar 2023
-
$2.00 M(-104.1%)
Dec 2022
-$48.40 M(-645.4%)
-$48.40 M(+5.2%)
Sep 2022
-
-$46.03 M(+285.5%)
Jun 2022
-
-$11.94 M(+127.7%)
Mar 2022
-
-$5.24 M(-159.1%)
Dec 2021
$8.88 M(-36.0%)
$8.88 M(-23.2%)
Sep 2021
-
$11.55 M(-61.0%)
Jun 2021
-
$29.58 M(-44.2%)
Mar 2021
-
$53.04 M(+282.6%)
Dec 2020
$13.86 M(-76.9%)
$13.86 M(-51.8%)
Sep 2020
-
$28.75 M(-16.9%)
Jun 2020
-
$34.59 M(-20.8%)
Mar 2020
-
$43.65 M(-27.3%)
Dec 2019
$60.00 M(+17.2%)
$60.00 M(+162.6%)
Sep 2019
-
$22.85 M(-28.4%)
Jun 2019
-
$31.90 M(-23.8%)
Mar 2019
-
$41.88 M(-18.2%)
Dec 2018
$51.19 M
$51.19 M(+28.5%)
Sep 2018
-
$39.84 M(+53.8%)
Jun 2018
-
$25.91 M(-28.6%)
DateAnnualQuarterly
Mar 2018
-
$36.29 M(-19.5%)
Dec 2017
$45.06 M(-28.1%)
$45.06 M(+32.7%)
Sep 2017
-
$33.96 M(-30.4%)
Jun 2017
-
$48.80 M(-17.2%)
Mar 2017
-
$58.95 M(-6.0%)
Dec 2016
$62.70 M(+4.4%)
$62.70 M(+54.9%)
Sep 2016
-
$40.48 M(-17.3%)
Jun 2016
-
$48.98 M(-10.8%)
Mar 2016
-
$54.94 M(-8.6%)
Dec 2015
$60.08 M(+140.2%)
$60.08 M(-9.2%)
Sep 2015
-
$66.19 M(+139.6%)
Jun 2015
-
$27.62 M(-18.5%)
Mar 2015
-
$33.89 M(+35.5%)
Dec 2014
$25.01 M(+109.7%)
$25.01 M(-16.5%)
Sep 2014
-
$29.94 M(-11.1%)
Jun 2014
-
$33.68 M(-9.1%)
Mar 2014
-
$37.05 M(+210.7%)
Dec 2013
$11.93 M(-37.3%)
$11.93 M(-16.6%)
Sep 2013
-
$14.29 M(-6.3%)
Jun 2013
-
$15.26 M(-12.1%)
Mar 2013
-
$17.36 M(-8.7%)
Dec 2012
$19.02 M(+1.2%)
$19.02 M(+41.1%)
Sep 2012
-
$13.48 M(-28.3%)
Dec 2011
$18.79 M
$18.79 M

FAQ

  • What is RedHill Biopharma annual stockholders equity?
  • What is the all time high annual shareholders equity for RedHill Biopharma?
  • What is RedHill Biopharma annual shareholders equity year-on-year change?
  • What is RedHill Biopharma quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for RedHill Biopharma?
  • What is RedHill Biopharma quarterly shareholders equity year-on-year change?

What is RedHill Biopharma annual stockholders equity?

The current annual shareholders equity of RDHL is $2.07 M

What is the all time high annual shareholders equity for RedHill Biopharma?

RedHill Biopharma all-time high annual stockholders equity is $62.70 M

What is RedHill Biopharma annual shareholders equity year-on-year change?

Over the past year, RDHL annual stockholders equity has changed by +$50.47 M (+104.27%)

What is RedHill Biopharma quarterly stockholders equity?

The current quarterly shareholders equity of RDHL is $61.00 K

What is the all time high quarterly shareholders equity for RedHill Biopharma?

RedHill Biopharma all-time high quarterly stockholders equity is $66.19 M

What is RedHill Biopharma quarterly shareholders equity year-on-year change?

Over the past year, RDHL quarterly stockholders equity has changed by -$3.41 M (-98.24%)